nrguidelines Posted December 26, 2019 Share Posted December 26, 2019 SPI009's chemical name is 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol. What kind of treatment would use this (oral ingestion? intravenous therapy?), and how might someone get this on the market? Here is some literature https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809444/ Link to comment Share on other sites More sharing options...
PhilGeis Posted December 29, 2019 Share Posted December 29, 2019 This would (in US) undergo drug approval process via NDA based on safety and efficacy. Appears the molecule is owned by Center for Drug Design and Discovery - I don;t see SPI009 mentioned on their website http://www.cd3.eu/- . Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now